- Home
- SELF vs ELOX Comparison
SELF vs ELOX Comparison
Compare SELF & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SELF | ELOX |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4M | 60.3M |
| IPO Year | 1997 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SELF | ELOX |
|---|---|---|
| Price | $4.97 | $14.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 30.7K | 22.5K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ 41.67 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $12,705,245.00 | N/A |
| Revenue This Year | $3.04 | N/A |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | $44.82 | ★ N/A |
| Revenue Growth | ★ 1.40 | N/A |
| 52 Week Low | $4.73 | $10.00 |
| 52 Week High | $5.75 | $23.40 |
Technical Indicators
Market Signals| Indicator | SELF | ELOX |
|---|---|---|
| Relative Strength Index (RSI) | 38.88 | 43.95 |
| Support Level | N/A | $13.92 |
| Resistance Level | $5.23 | $19.43 |
| Average True Range (ATR) | 0.11 | 1.55 |
| MACD | -0.02 | -0.23 |
| Stochastic Oscillator | 29.67 | 23.58 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About ELOX Eloxx Pharmaceuticals Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.